Endpoint Health Funding: $64M Raised, Series A (2022)
Endpoint Health is a Biotech company based in Palo Alto. It has raised $64M in total funding. Latest round: Series A.
Endpoint Health funding overview
Endpoint Health is a Biotech company based in Palo Alto. Endpoint Health has raised $64M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in June 2022. The round record for Endpoint Health runs through 2022; nothing later has been disclosed. Investors on record include Mayfield, Y Combinator, AME Cloud Ventures, Wireframe Ventures, Humboldt Fund, Boom Capital and 5 others. 11 distinct backers are named across the disclosed rounds.
Endpoint Health at a glance
Total raised
$64M
Latest round
Series A
Latest round date
June 2022
Industry
Biotech
Headquarters
Palo Alto
Notable investors
Mayfield, Y Combinator, AME Cloud Ventures, Wireframe Ventures, Humboldt Fund, Boom Capital, Alix Ventures, Yaya Capital
Frequently asked about Endpoint Health funding
How much has Endpoint Health raised?
Endpoint Health has raised $64M in total disclosed funding across the rounds on record.
Who has invested in Endpoint Health?
Mayfield, Y Combinator, AME Cloud Ventures, Wireframe Ventures, Humboldt Fund, Boom Capital are named among the investors backing Endpoint Health.
What was the latest Endpoint Health funding round?
The most recent disclosed round is a Series A, announced in June 2022.
Where is Endpoint Health based?
Endpoint Health is based in Palo Alto.
What sector does Endpoint Health operate in?
Endpoint Health is tracked under Biotech from Palo Alto, with $64M in disclosed funding.
When did Endpoint Health last raise?
The last disclosed Endpoint Health round closed in June 2022 at Series A.
Every Endpoint Health figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Palo Alto at a similar stage.
